Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1138 | SRRK Scholar Rock Holding Corporation - Common Stock | 56.50 USD | +2.26% | +8.65% | +16.18% | +88.21% | 6.88 B USD | ||
| 1185 | COGT Cogent Biosciences, Inc. - Common Stock | 36.73 USD | +4.02% | -3.21% | -8.29% | +134.40% | 6.37 B USD | ||
| 1192 | BLTE Belite Bio Inc - American Depositary Shares | 161.06 USD | -0.54% | -0.65% | +4.36% | +148.55% | 6.34 B USD | ||
| 1199 | MIRM Mirum Pharmaceuticals, Inc. - common stock | 96.31 USD | -0.78% | -3.62% | -16.36% | +37.33% | 6.25 B USD | ||
| 1206 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 111.10 USD | +1.45% | -3.66% | +6.99% | +357.20% | 6.21 B USD | ||
| 1207 | TVTX Travere Therapeutics, Inc. - Common Stock | 65.71 USD | +1.94% | +5.98% | +13.39% | +128.40% | 6.19 B USD | ||
| 1210 | ERAS Erasca, Inc. - Common Stock | 17.63 USD | +3.22% | -3.66% | -9.40% | +1015.82% | 6.17 B USD | ||
| 1212 | LQDA Liquidia Corporation - Common Stock | 68.62 USD | -3.42% | -7.01% | -20.39% | +203.63% | 6.14 B USD | ||
| 1230 | DFTX Definium Therapeutics, Inc. - Common Shares | 44.91 USD | -1.08% | +6.42% | +2.89% | +197.22% | 6.03 B USD | ||
| 1240 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 60.77 USD | +1.74% | -1.95% | -7.29% | +48.98% | 5.88 B USD | ||
| 1251 | PTCT PTC Therapeutics, Inc. - Common Stock | 69.82 USD | -0.99% | -2.62% | -10.05% | +37.88% | 5.83 B USD | ||
| 1260 | CRSP CRISPR Therapeutics AG - Common Shares | 59.50 USD | +2.37% | +12.09% | +24.84% | +9.68% | 5.75 B USD | ||
| 1266 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 286.29 USD | -0.38% | -2.11% | -6.13% | +53.00% | 5.71 B USD | ||
| 1344 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.50 USD | +1.58% | +3.04% | +17.02% | +14.96% | 5.08 B USD | ||
| 1372 | DYN Dyne Therapeutics, Inc. - Common Stock | 26.10 USD | +0.46% | +0.77% | +4.40% | +11.49% | 4.87 B USD | ||
| 1382 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 44.18 USD | +2.06% | +0.91% | +6.20% | +190.09% | 4.80 B USD | ||
| 1418 | CELC Celcuity Inc. - Common Stock | 93.53 USD | +3.27% | +0.58% | +11.20% | +76.74% | 4.58 B USD | ||
| 1449 | ELVN Enliven Therapeutics, Inc. - Common Stock | 59.82 USD | +1.53% | +1.89% | +11.23% | +189.55% | 4.38 B USD | ||
| 1468 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 38.66 USD | -2.52% | +76.05% | +108.97% | +316.59% | 4.31 B USD | ||
| 1477 | RLAY Relay Therapeutics, Inc. - Common Stock | 19.44 USD | -1.32% | -1.42% | +5.25% | +426.83% | 4.26 B USD |
Notícias Biotechnology Stocks
Ações da Capricor disparam após extensão de prazo pela FDA
FDA prorroga revisão do Deramiocel da Capricor para novembro
GRI Bio apresentará dados de estudo fase 2a sobre fibrose pulmonar no congresso ERS
Alnylam apresentará dados clínicos sobre ATTR e hipertensão no ESC 2026
Lexicon recebe US$ 10 milhões da Novo Nordisk por marco em droga para obesidade
FibroBiologics nomeia Leigh Steinberg para seu conselho de administração
FDA confirma reunião sobre cateter Helix da BioCardia
Gainers Biotechnology Stocks
LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |